CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 enrolled
Drug / intervention
Isosorbide Dinitrate +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02488642
NCT02488642Phase 4Completed
CompareCT.gov

Medical Management of Late Intrauterine Death Using a Therapeutic Combination of Isosorbide Dinitrate and Oxytocin.

National Institute of Perinatology·interventional·Posted Jul 2, 2015·Updated Jul 24, 2015

In Brief

A Phase 4 clinical trial evaluating Isosorbide Dinitrate, Misoprostol, and 1 other intervention for Cervical Pregnancy and Maternal Care for Late Fetal Death. Completed, enrolled 60 participants.

Detailed Summary

The purpose of this study is to assess the therapeutic efficacy and safety of isosorbide dinitrate-oxytocin in combination in the management of late intrauterine foetal death.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Pregnancy, Maternal Care for Late Fetal Death
Countries--
CollaboratorsNational Council of Science and Technology, Mexico

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 2, 2015
Enrollment StartMay 1, 2008
Primary CompletionSep 1, 2013
Study CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 11 years ago

Interventions

Isosorbide Dinitratedrug

Misoprostoldrug

Oxytocindrug

Oxytocin was infused in a balanced electrolyte solution beginning with an infusion rate of 2 milli-International Units per minute (mIU/min) and doubling the dose every 15 minutes.